Dow Jones

40,211.72

0.53%

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

XLRN

Acceleron Pharma (XLRN)

Acceleron Pharma Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:XLRN

<< Anterior 1 2 3 4 5 6 7 8 9 10 11 12 13 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
05/05/2016	06:00	Business Wire	Acceleron Pharma Reports First Quarter 2016 Financial and Operational Results	NASDAQ:XLRN	Acceleron Pharma Inc
28/04/2016	15:05	Business Wire	Acceleron Pharma to Host First Quarter 2016 Financial Results	NASDAQ:XLRN	Acceleron Pharma Inc
26/04/2016	15:30	Business Wire	Acceleron Pharma to Participate in Two Healthcare Investor Conferences in May	NASDAQ:XLRN	Acceleron Pharma Inc
15/04/2016	15:07	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:XLRN	Acceleron Pharma Inc
15/04/2016	15:04	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:XLRN	Acceleron Pharma Inc
08/04/2016	15:04	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:XLRN	Acceleron Pharma Inc
01/03/2016	06:00	Business Wire	Acceleron Pharma to Participate in Four Healthcare Investor Conferences in March	NASDAQ:XLRN	Acceleron Pharma Inc
25/02/2016	06:06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:XLRN	Acceleron Pharma Inc
25/02/2016	06:00	Business Wire	Acceleron Pharma Reports Fourth Quarter and Year Ended 2015 Financial and Operational Results and Recent Highlights	NASDAQ:XLRN	Acceleron Pharma Inc
18/02/2016	06:00	Business Wire	Acceleron Pharma to Host Fourth Quarter and Year Ended 2015 Financial Results	NASDAQ:XLRN	Acceleron Pharma Inc
16/02/2016	10:04	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:XLRN	Acceleron Pharma Inc
01/02/2016	06:00	Business Wire	Acceleron Pharma to Participate in Two Healthcare Investor Conferences in February	NASDAQ:XLRN	Acceleron Pharma Inc
11/01/2016	15:18	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:XLRN	Acceleron Pharma Inc
06/01/2016	15:13	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:XLRN	Acceleron Pharma Inc
05/01/2016	18:35	Business Wire	Acceleron Announces Pricing of Public Offering of Common Stock	NASDAQ:XLRN	Acceleron Pharma Inc
04/01/2016	15:58	Business Wire	Acceleron Announces Proposed Public Offering of Common Stock	NASDAQ:XLRN	Acceleron Pharma Inc
04/01/2016	15:28	Edgar (US Regulatory)	Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)	NASDAQ:XLRN	Acceleron Pharma Inc
07/12/2015	16:00	Business Wire	Celgene & Acceleron Announce New Results from an Investigational Study with Luspatercept in Beta-Thalassemia Presented at the...	NASDAQ:XLRN	Acceleron Pharma Inc
07/12/2015	06:00	Business Wire	FDA Fast Track Designation Granted to Luspatercept for the Treatment of Patients with Lower-Risk Myelodysplastic Syndromes	NASDAQ:XLRN	Acceleron Pharma Inc
05/12/2015	11:30	Business Wire	Celgene & Acceleron Announce New Results from an Investigational Study with Luspatercept in Myelodysplastic Syndromes Present...	NASDAQ:XLRN	Acceleron Pharma Inc
01/12/2015	06:00	Business Wire	Acceleron Announces Oral Plenary Presentation for ACE-083 in the Late Breaking Clinical Trials Session at the 8th Internation...	NASDAQ:XLRN	Acceleron Pharma Inc
24/11/2015	15:05	Business Wire	Acceleron Pharma to Present at Piper Jaffray 27th Annual Healthcare Conference	NASDAQ:XLRN	Acceleron Pharma Inc
09/11/2015	14:41	The Motley Fool	3 Biotech Stocks That Are Rocketing Higher	NASDAQ:XLRN	Acceleron Pharma Inc
05/11/2015	08:10	Business Wire	Acceleron Announces New Data Presentations at the 2015 American Society of Hematology Annual Meeting	NASDAQ:XLRN	Acceleron Pharma Inc
04/11/2015	06:43	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:XLRN	Acceleron Pharma Inc
04/11/2015	06:00	Business Wire	Acceleron Pharma Reports Third Quarter 2015 Financial and Operational Results	NASDAQ:XLRN	Acceleron Pharma Inc
02/11/2015	06:00	Business Wire	Acceleron Pharma to Present at Upcoming Investor Conferences in November	NASDAQ:XLRN	Acceleron Pharma Inc
29/10/2015	06:00	Business Wire	Acceleron Pharma to Host Third Quarter 2015 Financial Results Conference Call and Webcast on November 4, 2015	NASDAQ:XLRN	Acceleron Pharma Inc
23/10/2015	11:00	Business Wire	Acceleron Highlights Phase 3 Studies, New Clinical Results and Research Strategies at Research and Development Day Event	NASDAQ:XLRN	Acceleron Pharma Inc
15/10/2015	06:30	Business Wire	Acceleron to Host Research and Development Day on October 23	NASDAQ:XLRN	Acceleron Pharma Inc